{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:53:17Z","timestamp":1787503997892,"version":"build-2736575974"},"reference-count":104,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:00:00Z","timestamp":1583798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00383","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:26:10Z","timestamp":1583799970000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":59,"title":["Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis"],"prefix":"10.3389","volume":"11","author":[{"given":"Ludivine","family":"Renaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willian A.","family":"da Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Takamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Hardiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Feghali-Bostwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972\u20132002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis."},{"key":"B2","first-page":"733","article-title":"Myofibroblast induction and microvascular alteration in scleroderma lung fibrosis","volume":"22","author":"Beon","year":"2004","journal-title":"Clin Exp Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/art.30647","article-title":"Localized expression of tenascin in systemic sclerosis\u2013associated pulmonary fibrosis and its regulation by insulin-like growth factor binding protein 3","volume":"64","author":"Brissett","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B4","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J Pathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/art.38702","article-title":"Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct?","volume":"66","author":"Herzog","year":"2014","journal-title":"Arthritis Rheum."},{"key":"B6","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1183\/09031936.05.00071004","article-title":"Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia","volume":"25","author":"Kondoh","year":"2005","journal-title":"Eur Respir J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1164\/ajrccm-conference.2011.183.1_MeetingAbstracts.A1537","article-title":"Effect and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis. A retrospective study","volume":"38","author":"Tzouvelekis","year":"2011","journal-title":"Eur Respir Soc."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N Engl J Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1136\/annrheumdis-2016-210823","article-title":"Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis","volume":"76","author":"Huang","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis\u2013associated interstitial lung disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/art.30262","article-title":"Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma","volume":"63","author":"Castelino","year":"2011","journal-title":"Arthritis Rheum."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.chest.2018.08.1058","article-title":"Randomized, double-blind, placebo-controlled, phase 2 trial of BMS-986020, a lysophosphatidic acid receptor antagonist for the treatment of idiopathic pulmonary fibrosis","volume":"154","author":"Palmer","year":"2018","journal-title":"Chest."},{"key":"B14","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3892\/etm.2019.7579","article-title":"Efficacy and safety of N-acetylcysteine therapy for idiopathic pulmonary fibrosis: an updated systematic review and meta-analysis","volume":"18","author":"Fen","year":"2019","journal-title":"Exp Ther Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1177\/039463201102400319","article-title":"Long-term N-acetylcysteine therapy in systemic sclerosis interstitial lung disease: a retrospective study","volume":"24","author":"Rosato","year":"2011","journal-title":"Int J Immunopathol Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1126\/science.1069492","article-title":"Systems biology: a brief overview","volume":"295","author":"Kitano","year":"2002","journal-title":"Science."},{"key":"B17","doi-asserted-by":"publisher","first-page":"D433","DOI":"10.1093\/nar\/gki005","article-title":"STRING: known and predicted protein\u2013protein associations, integrated and transferred across organisms","volume":"33","author":"von Mering","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Subcommittee for scleroderma criteria of the american rheumatism association diagnostic and therapeutic criteria committee. preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"Masi","year":"1980","journal-title":"Arthritis Rheum."},{"key":"B19","doi-asserted-by":"publisher","first-page":"W305","DOI":"10.1093\/nar\/gkp427","article-title":"ToppGene Suite for gene list enrichment analysis and candidate gene prioritization","volume":"37","author":"Chen","year":"2009","journal-title":"Nucleic acids Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e21800","DOI":"10.1371\/journal.pone.0021800","article-title":"REVIGO summarizes and visualizes long lists of gene ontology terms","volume":"6","author":"Supek","year":"2011","journal-title":"PloS ONE."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1101\/gr.6202607","article-title":"A systems biology approach for pathway level analysis","volume":"17","author":"Draghici","year":"2007","journal-title":"Genome Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.3899\/jrheum.080340","article-title":"Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis","volume":"35","author":"Hamaguchi","year":"2008","journal-title":"J Rheum."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.2353\/ajpath.2008.071021","article-title":"Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase-and phosphatidylinositol-3 kinase-dependent pathways","volume":"172","author":"Hsu","year":"2008","journal-title":"Am J Pathol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/art.30159","article-title":"Lung tissues in systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension","volume":"63","author":"Hsu","year":"2011","journal-title":"Arthritis Rheum."},{"key":"B25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0002-9440(10)62263-8","article-title":"Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition","volume":"166","author":"Pilewski","year":"2005","journal-title":"Am J Pathol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3389\/fendo.2018.00601","article-title":"IGFBP-5 promotes fibrosis via increasing its own expression and that of other pro-fibrotic mediators","volume":"9","author":"Nguyen","year":"2018","journal-title":"Front Endocrinol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1096\/fba.2018-00015","article-title":"Insulin-like growth factor binding protein-4 exerts antifibrotic activity by reducing levels of connective tissue growth factor and the C-X-C chemokine receptor 4","volume":"1","author":"Su","year":"2019","journal-title":"FASEB BioAdv."},{"key":"B28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1164\/rccm.200504-644OC","article-title":"Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis","volume":"173","author":"Selman","year":"2006","journal-title":"Am J Respir Crit Care Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"6292","DOI":"10.1073\/pnas.092134099","article-title":"Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans","volume":"99","author":"Zuo","year":"2002","journal-title":"Proc Natl Acad Sci USA."},{"key":"B30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.critrevonc.2003.06.007","article-title":"An introduction to matrikines: extracellular matrix-derived peptides which regulate cell activity: implication in tumor invasion","volume":"49","author":"Maquart","year":"2004","journal-title":"Crit Rev Oncol Hemat."},{"key":"B31","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/exd.12435","article-title":"Matricryptins and matrikines: biologically active fragments of the extracellular matrix","volume":"23","author":"Ricard-Blum","year":"2014","journal-title":"Exp Dermatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"S702","DOI":"10.4137\/GRSB.S702","article-title":"Centrality analysis methods for biological networks and their application to gene regulatory networks","volume":"2","author":"Kosch\u00fctzki","year":"2008","journal-title":"Gene Regul Syst Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/35075138","article-title":"Lethality and centrality in protein networks","volume":"411","author":"Jeong","year":"2001","journal-title":"Nature."},{"key":"B34","doi-asserted-by":"publisher","first-page":"R120","DOI":"10.1186\/ar1038","article-title":"IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-\u03baB-and PI3-kinase\/Akt-dependent pathways","volume":"6","author":"Hwang","year":"2004","journal-title":"Arthritis Res Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"721608","DOI":"10.1155\/2011\/721608","article-title":"The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis","volume":"2011","author":"Barnes","year":"2011","journal-title":"Int J Rheumatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1378\/chest.120.1_suppl.S5","article-title":"Type 1\/Type 2 cytokine paradigm and the progression of pulmonary fibrosis","volume":"120","author":"Lukacs","year":"2001","journal-title":"Chest."},{"key":"B37","first-page":"1207","article-title":"Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma","volume":"19","author":"Feghali","year":"1992","journal-title":"J Rheumatol."},{"key":"B38","first-page":"291","article-title":"Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1","volume":"23","author":"Giacomelli","year":"1996","journal-title":"J Rheum."},{"key":"B39","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S1074-7613(00)80334-9","article-title":"Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment","volume":"6","author":"Romano","year":"1997","journal-title":"Immunity."},{"key":"B40","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.autrev.2015.10.005","article-title":"Systemic sclerosis: new evidence re-enforces the role of B cells","volume":"15","author":"Sakkas","year":"2016","journal-title":"Autoimmun Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40169-015-0047-4","article-title":"The significance of macrophage polarization subtypes for animal models of tissue fibrosis and human fibrotic diseases","volume":"4","author":"Wermuth","year":"2015","journal-title":"Clin Transl Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1136\/annrheumdis-2011-200955","article-title":"Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis","volume":"71","author":"Khan","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.it.2009.05.007","article-title":"The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology","volume":"30","author":"Vereecke","year":"2009","journal-title":"Trends Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"6592","DOI":"10.3390\/ijms15046592","article-title":"A20 overexpression inhibits lipopolysaccharide-induced NF-\u03baB activation, TRAF6 and CD40 expression in rat peritoneal mesothelial cells","volume":"15","author":"Zou","year":"2014","journal-title":"Int J Mol Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jmb.2007.11.092","article-title":"Molecular basis for the unique deubiquitinating activity of the NF-\u03baB inhibitor A20","volume":"376","author":"Lin","year":"2008","journal-title":"J Mol Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nature02794","article-title":"De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-\u03baB signalling","volume":"430","author":"Wertz","year":"2004","journal-title":"Nature."},{"key":"B47","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jaci.2017.11.024","article-title":"TNF-\u03b1-induced protein 3 (TNFAIP3)\/A20 acts as a master switch in TNF-\u03b1 blockade\u2013driven IL-17A expression","volume":"142","author":"Urbano","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/intimm\/dxu102","article-title":"Anti-TNF therapy: past, present and future","volume":"27","author":"Monaco","year":"2015","journal-title":"Int Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1080\/09546630802441234","article-title":"Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases","volume":"20","author":"Ko","year":"2009","journal-title":"J Dermatolog Treat."},{"key":"B50","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3899\/jrheum.120725","article-title":"Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis","volume":"40","author":"De Lauretis","year":"2013","journal-title":"J Rheumatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000163802","article-title":"In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis","volume":"61","author":"Koch","year":"1993","journal-title":"Pathobiology."},{"key":"B52","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.4049\/jimmunol.1302470","article-title":"Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis","volume":"193","author":"Le","year":"2014","journal-title":"J Immunol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1136\/annrheumdis-2017-211682","article-title":"Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)","volume":"77","author":"Khanna","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/bdrc.10022","article-title":"Biology of insulin-like growth factors in development","volume":"69","author":"Dupont","year":"2003","journal-title":"Birth Defects Res C."},{"key":"B55","doi-asserted-by":"publisher","first-page":"PA3840","DOI":"10.1183\/13993003.congress-2015.PA3840","article-title":"Serum IGFBP2 as a marker of idiopathic pulmonary fibrosis","volume":"46","author":"Guiot","year":"2015","journal-title":"Eur Respiratory Soc."},{"key":"B56","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12890-016-0249-6","article-title":"Raised serum levels of IGFBP-1 and IGFBP-2 in idiopathic pulmonary fibrosis","volume":"16","author":"Guiot","year":"2016","journal-title":"BMC Pulm. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jid.2016.08.027","article-title":"A proteome-derived longitudinal pharmacodynamic biomarker for diffuse systemic sclerosis skin","volume":"137","author":"Rice","year":"2017","journal-title":"J Invest Dermatol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s10067-012-1962-z","article-title":"Supernatants from culture of type I collagen-stimulated PBMC from patients with cutaneous systemic sclerosis versus localized scleroderma demonstrate suppression of MMP-1 by fibroblasts","volume":"31","author":"Brown","year":"2012","journal-title":"Clin Rheumatol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.gendis.2014.10.004","article-title":"Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance","volume":"2","author":"Denduluri","year":"2015","journal-title":"Genes Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1002\/art.22084","article-title":"Insulin-like growth factor binding protein 5 induces skin fibrosis: a novel murine model for dermal fibrosis","volume":"54","author":"Yasuoka","year":"2006","journal-title":"Arthritis Rheum."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.2353\/ajpath.2006.060501","article-title":"Insulin-like growth factor-binding protein-5 induces pulmonary fibrosis and triggers mononuclear cellular infiltration","volume":"169","author":"Yasuoka","year":"2006","journal-title":"Am J Pathol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e87754","DOI":"10.1371\/journal.pone.0087754","article-title":"The membrane-associated adaptor protein DOK5 is upregulated in systemic sclerosis and associated with IGFBP-5-induced fibrosis","volume":"9","author":"Yasuoka","year":"2014","journal-title":"PloS ONE."},{"key":"B63","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2353\/ajpath.2009.080991","article-title":"The fibrotic phenotype induced by IGFBP-5 is regulated by MAPK activation and egr-1-dependent and-independent mechanisms","volume":"175","author":"Yasuoka","year":"2009","journal-title":"Am J Pathol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2174\/1874312900802010017","article-title":"Human skin culture as an ex vivo model for assessing the fibrotic effects of insulin-like growth factor binding proteins","volume":"2","author":"Yasuoka","year":"2008","journal-title":"Open Rheumatol J."},{"key":"B65","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ygeno.2006.05.012","article-title":"IGFL: a secreted family with conserved cysteine residues and similarities to the IGF superfamily","volume":"88","author":"Emtage","year":"2006","journal-title":"Genomics."},{"key":"B66","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.addr.2017.07.014","article-title":"The good and the bad collagens of fibrosis\u2013their role in signaling and organ function","volume":"121","author":"Karsdal","year":"2017","journal-title":"Adv Drug Deliv Rev."},{"key":"B67","doi-asserted-by":"publisher","first-page":"25937","DOI":"10.1074\/jbc.273.40.25937","article-title":"Two forms of collagen XVII in keratinocytes: a full-length transmembrane protein and a soluble ectodomain","volume":"273","author":"Sch\u00e4cke","year":"1998","journal-title":"J Biol Chem."},{"key":"B68","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1042\/bj2700459","article-title":"Activation of human neutrophils by type I collagen. Requirement of two different sequences","volume":"270","author":"Monboisse","year":"1990","journal-title":"Biochem J."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.jacc.2015.07.035","article-title":"A novel collagen matricryptin reduces left ventricular dilation post-myocardial infarction by promoting scar formation and angiogenesis","volume":"66","author":"Lindsey","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1163\/156856208784909435","article-title":"The human tri-peptide GHK and tissue remodeling","volume":"19","author":"Pickart","year":"2008","journal-title":"J Biomater Sci Polym Ed."},{"key":"B71","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3389\/fphar.2017.00904","article-title":"GHK peptide inhibits bleomycin-induced pulmonary fibrosis in mice by suppressing TGF?1\/SMAD-mediated epithelial-to-mesenchymal transition","volume":"8","author":"Zhou","year":"2017","journal-title":"Front Pharmacol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0945-053X(01)00151-2","article-title":"The role of collagen-derived proteolytic fragments in angiogenesis","volume":"20","author":"Marneros","year":"2001","journal-title":"Matrix Biol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bbapap.2004.10.013","article-title":"Identification and characterization of novel endogenous proteolytic forms of the human angiogenesis inhibitors restin and endostatin","volume":"1747","author":"John","year":"2005","journal-title":"Biochim Biophys Acta."},{"key":"B74","doi-asserted-by":"publisher","first-page":"23386","DOI":"10.1074\/jbc.M109.034090","article-title":"Shedding of collagen XVII\/BP180 in skin depends on both ADAM10 and ADAM9","volume":"284","author":"Franzke","year":"2009","journal-title":"J Biol Chem."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3389\/fimmu.2017.01752","article-title":"BP180 is critical in the autoimmunity of bullous pemphigoid","volume":"8","author":"Liu","year":"2017","journal-title":"Front Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.matbio.2011.09.003","article-title":"Neutrophil elastase cleaves the murine hemidesmosomal protein BP180\/type XVII collagen and generates degradation products that modulate experimental bullous pemphigoid","volume":"31","author":"Lin","year":"2012","journal-title":"Matrix Biol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0065-3233(05)70008-5","article-title":"Fibrinogen and fibrin","volume":"70","author":"Weisel","year":"2005","journal-title":"Adv Protein Chem"},{"key":"B78","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12890-016-0356-4","article-title":"Identification and validation of differentially expressed transcripts by RNA-sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with idiopathic pulmonary fibrosis","volume":"17","author":"Vukmirovic","year":"2017","journal-title":"BMC Pulm Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1513\/pats.201201-006AW","article-title":"Coagulation cascade proteinases in lung injury and fibrosis","volume":"9","author":"Chambers","year":"2012","journal-title":"Proc Am Thorac Soc."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1172\/JCI38369","article-title":"The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice","volume":"120","author":"Bauman","year":"2010","journal-title":"J Clin Invest."},{"key":"B81","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1476-9255-7-57","article-title":"The role of toll-like receptors in acute and chronic lung inflammation","volume":"7","author":"Lafferty","year":"2010","journal-title":"J Inflamm."},{"key":"B82","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejphar.2016.06.045","article-title":"Toll-like receptors in the pathogenesis of pulmonary fibrosis","volume":"808","author":"Karampitsakos","year":"2017","journal-title":"Eur J Pharmacol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1002\/art.24049","article-title":"Antifibroblast antibodies in systemic sclerosis induce fibroblasts to produce profibrotic chemokines, with partial exploitation of toll-like receptor 4","volume":"58","author":"Fineschi","year":"2008","journal-title":"Arthritis Rheum J Am Coll Rheumatol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ajpath.2012.09.007","article-title":"Toll-Like receptor 4 signaling augments transforming growth factor-\u03b2 responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma","volume":"182","author":"Bhattacharyya","year":"2013","journal-title":"Am J Pathol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1755-1536-3-20","article-title":"Investigation of Toll-like receptors in the pathogenesis of fibrotic and granulomatous disorders: a bronchoalveolar lavage study","volume":"3","author":"Margaritopoulos","year":"2010","journal-title":"Fibrogenesis Tissue Repair."},{"key":"B86","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1165\/rcmb.2018-0373OC","article-title":"Toll-like receptor 8 stability is regulated by ring finger 216 in response to circulating microRNAs","volume":"62","author":"Evankovich","year":"2020","journal-title":"Am J Respir Cell Mole Biol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"eaam8458","DOI":"10.1126\/scitranslmed.aam8458","article-title":"Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8","volume":"10","author":"Kioon","year":"2018","journal-title":"Sci Transl Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.coph.2015.05.017","article-title":"PI3K inhibitors in inflammation, autoimmunity and cancer","volume":"23","author":"Stark","year":"2015","journal-title":"Curr Opin Pharmacol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.autrev.2006.12.006","article-title":"Vascular complications of scleroderma","volume":"6","author":"Guiducci","year":"2007","journal-title":"Autoimmun Rev."},{"key":"B90","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1093\/jn\/138.10.2021S","article-title":"Proline precursors to sustain mammalian collagen synthesis","volume":"138","author":"Barbul","year":"2008","journal-title":"J Nutr."},{"key":"B91","doi-asserted-by":"publisher","first-page":"9671919","DOI":"10.1155\/2018\/9671919","article-title":"Tributyrin supplementation protects immune responses and vasculature and reduces oxidative stress in the proximal colon of mice exposed to chronic-binge ethanol feeding","volume":"2018","author":"Glueck","year":"2018","journal-title":"J Immunol Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10456-013-9381-6","article-title":"Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo","volume":"17","author":"Jetten","year":"2014","journal-title":"Angiogenesis."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1002\/eji.201141869","article-title":"Macrophage activation governs schistosomiasis-induced inflammation and fibrosis","volume":"41","author":"Barron","year":"2011","journal-title":"Eur J Immunol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/j.1476-5381.2009.00291.x","article-title":"Arginase: an emerging key player in the mammalian immune system","volume":"158","author":"Munder","year":"2009","journal-title":"Br J Pharmacol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1096\/fj.03-0473com","article-title":"Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis","volume":"18","author":"Kuwano","year":"2004","journal-title":"FASEB J."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/nm.2066","article-title":"Prostaglandin F 2\u03b1 receptor signaling facilitates bleomycin-induced pulmonary fibrosis independently of transforming growth factor-\u03b2","volume":"15","author":"Oga","year":"2009","journal-title":"Nat Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1074\/jbc.RA117.000444","article-title":"Glutaminolysis is required for transforming growth factor-\u03b21\u2013induced myofibroblast differentiation and activation","volume":"293","author":"Bernard","year":"2018","journal-title":"J Biol Chem."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s41591-018-0087-6","article-title":"Metformin reverses established lung fibrosis in a bleomycin model","volume":"24","author":"Rangarajan","year":"2018","journal-title":"Nat Med."},{"key":"B99","doi-asserted-by":"publisher","first-page":"eaav3048","DOI":"10.1126\/scisignal.aav3048","article-title":"mTORC1 amplifies the ATF4-dependent de novo serine-glycine pathway to supply glycine during TGF-\u03b21\u2013induced collagen biosynthesis","volume":"12","author":"Selvarajah","year":"2019","journal-title":"Sci Signal."},{"key":"B100","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s42255-018-0008-5","article-title":"Metabolic regulation of dermal fibroblasts contributes to skin extracellular matrix homeostasis and fibrosis","volume":"1","author":"Zhao","year":"2019","journal-title":"Nat Metab."},{"key":"B101","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O'Neill","year":"2016","journal-title":"Nat Rev Immunol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/cr.2015.68","article-title":"Metabolic reprogramming in macrophages and dendritic cells in innate immunity","volume":"25","author":"Kelly","year":"2015","journal-title":"Cell Res."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1164\/rccm.201504-0780OC","article-title":"Glycolytic reprogramming in myofibroblast differentiation and lung fibrosis","volume":"192","author":"Xie","year":"2015","journal-title":"Am J Respir Crit Care Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development","volume":"21","author":"Kang","year":"2015","journal-title":"Nat. Med."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00383\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T00:26:18Z","timestamp":1583799978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00383\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,10]]},"references-count":104,"alternative-id":["10.3389\/fimmu.2020.00383"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00383","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,10]]},"article-number":"383"}}